Impact of Pollution on Device Demand
Air quality deterioration remains a major driver for the Asia Pacific Respiratory Therapeutic Devices Market. Countries like India and China face severe air pollution levels, leading to a surge in respiratory disorders. Asthma, COPD, and bronchitis cases have sharply increased over the past decade, creating heightened demand for therapeutic devices such as nebulizers and oxygen therapy systems.
The COVID-19 pandemic further amplified awareness about respiratory health, leading to a dramatic rise in the use of oxygen concentrators and ventilators across households and hospitals. The region’s governments are also enforcing stricter pollution control measures, yet the need for respiratory support devices remains pressing. Device manufacturers are responding with portable, cost-effective solutions suitable for both hospital and home care.
The discussion on this market often revolves around whether addressing environmental pollution could reduce reliance on therapeutic devices. While preventive measures are critical, the increasing prevalence of chronic diseases ensures that demand for respiratory devices will continue to rise. This dual challenge highlights the importance of innovation and accessibility in sustaining market growth.